Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $195,950 - $247,359
-1,107 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$181.39 - $202.99 $24,306 - $27,200
-134 Reduced 10.8%
1,107 $201,000
Q2 2021

Aug 12, 2021

BUY
$187.49 - $221.1 $51,184 - $60,360
273 Added 28.2%
1,241 $250,000
Q1 2021

May 12, 2021

BUY
$207.02 - $241.31 $200,395 - $233,588
968 New
968 $208,000
Q3 2020

Nov 12, 2020

SELL
$255.65 - $303.1 $279,936 - $331,894
-1,095 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$225.48 - $295.8 $246,900 - $323,901
1,095 New
1,095 $318,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Quilter PLC Portfolio

Follow Quilter PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quilter PLC, based on Form 13F filings with the SEC.

News

Stay updated on Quilter PLC with notifications on news.